Dyadic International, Inc. (NASDAQ:DYAI - Get Free Report) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.48 and traded as high as $1.93. Dyadic International shares last traded at $1.75, with a volume of 265,677 shares changing hands.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reiterated a "buy" rating and set a $6.00 price target on shares of Dyadic International in a research note on Thursday, November 14th.
Read Our Latest Analysis on DYAI
Dyadic International Trading Down 0.6 %
The business has a 50-day moving average of $1.49 and a 200-day moving average of $1.39. The stock has a market capitalization of $51.48 million, a price-to-earnings ratio of -7.56 and a beta of 0.89. The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15.
Dyadic International (NASDAQ:DYAI - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.06. The business had revenue of $1.96 million during the quarter, compared to the consensus estimate of $1.05 million. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%. During the same period in the prior year, the company earned ($0.06) earnings per share. As a group, research analysts forecast that Dyadic International, Inc. will post -0.18 EPS for the current year.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Dyadic International stock. Chapin Davis Inc. increased its stake in shares of Dyadic International, Inc. (NASDAQ:DYAI - Free Report) by 2.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 868,301 shares of the biotechnology company's stock after buying an additional 21,000 shares during the quarter. Chapin Davis Inc. owned about 2.97% of Dyadic International worth $903,000 at the end of the most recent quarter. 27.95% of the stock is owned by institutional investors.
About Dyadic International
(
Get Free Report)
Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.
See Also
Before you consider Dyadic International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dyadic International wasn't on the list.
While Dyadic International currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
